Reassessment of 4-Cycle Etoposide and Cisplatin in Good-Risk Metastatic Germ Cell Tumors

This Viewpoint assesses the current recommendation of treatment regimens with and without bleomycin for patients with metastatic germ cell tumors of the testis.

https://ift.tt/2yd05II